Latigo Biotherapeutics (LTGO)
Latigo Biotherapeutics, Inc. develops non-opioid pain medicines designed to stop the transmission of pain without the risk of addiction. The company's pipeline...
- Open
- 19.170
- High
- 20.045
- Low
- 19.000
- Prev. Close
- 19.300
- Volume
- 254.99K
- Turnover
- 5.00M
- Avg Price
- 19.619
- Bid/Ask Ratio
- 0.00%
- Amplitude
- 5.41%
- 52wk High
- 22.470
- Volume Ratio
- 0.00
- Turnover Ratio
- 0.92%
News
- PUBT · Aug 12 at 07:10 AM
Latigo Biotherapeutics files initial beneficial ownership statement for Sanofi
- Global Report · Aug 11 at 05:13 AM
The Structural Pivot: How Niche Micro-Caps Navigate the Aggregation Era
- PUBT · Aug 10 at 07:00 PM
Foresite’s James Tananbaum acquires 140,000 Latigo Biotherapeutics shares for $2.52 million
- PUBT · Aug 10 at 03:04 PM
Latigo Biotherapeutics adopts amended and restated bylaws tied to IPO close
